1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine has been researched along with Seizures in 1 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Page, JG; Stabin, MG; Waterhouse, RN | 1 |
1 other study(ies) available for 1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine and Seizures
| Article | Year |
|---|---|
Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; In Vitro Techniques; Leukocyte Count; Organ Specificity; Piperidines; Rabbits; Radiation Dosage; Radiometry; Radiopharmaceuticals; Rats; Seizures; Species Specificity; Tissue Distribution; Toxicity Tests | 2003 |